RxDoctor Payments Data

Andrew Barksdale, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Indianapolis, INNPI 1538363247

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $124,500 of the $158,012 with a category attached, or 78.8%. Atricure, Inc. accounts for 88.9% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2019 at $79,966 and has fallen 97.4% since, to $2,112 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$158,012in general payments, 2019–2025

Across 406 payments — averaging $389.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Atricure, Inc.$140K
  • Edwards Lifesciences$10K
  • Clearflow Inc.$2K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$990
  • Abiomed$946
  • Artivion, Inc.$780
  • plus $3K from 26 others

What the payments were for

  • Consulting fees$124,50079%
  • Travel & lodging$23,15715%
  • Food & beverage$10,3557%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$158,012 in reported general payments places this provider in the 95th percentile of 127 thoracic surgery (cardiothoracic vascular surgery) providers in Indiana.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Indiana

Medicare billing

Part B allowed, 2024
$120,869
Medicare patients
92
Services billed
303

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate15$153
Metoprolol Succinate15$91
Atorvastatin Calcium20$59

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →